期刊文献+

血清降钙素原及IL-6检测在慢性阻塞性肺疾病患者诊治中的意义 被引量:3

Clinical significance of serum procalcitonin and IL-6 detection in diagnosis and treatment of patients with chronic obstructive pulmonary disease
暂未订购
导出
摘要 目的探讨血清降钙素原(PCT)及白介素6(IL-6)检测在慢性阻塞性肺疾病(COPD)诊治中的意义。方法采用电化学发光分析法检测160例COPD患者(观察组)及110例健康对照者(对照组)的PCT及IL-6水平,并比较2组敏感性和特异性。结果观察组PCT、IL-6的水平均显著高于对照组(P<0.05);IL-6敏感性高于PCI(P<0.05),而PCT特异性高于IL-6(P<0.05)。结论 PCT和IL-6检测在COPD诊治中具有重要的临床价值,但二者在敏感性和特异性上存在差异。 Objective To explore clinical significance of serum procalcitonin (PCT)and in-terleukin-6 (IL-6)detection in the diagnosis and treatment of patients with chronic obstructive pul-monary disease (COPD).Methods Electrochemical luminescence analysis was used to detect the levels of PCT and IL-6 in 160 COPD patients (observation group)and 110 normal people (control group),and sensitivity and specificity of PCT and IL-6 were compared.Results Levels of PCT and IL-6 in the observation group were significantly higher than those in the control group (P 〈0.05).Sensitivity of IL-6 was significantly higher than that of PCT (P 〈0.05),while specificity of PCT was significantly higher than that of IL-6 (P 〈0.05).Conclusion PCT and IL-6 detec-tion play an important role in the diagnosis and treatment of COPD,but there are differences of sen-sitivity and specificity between PCT and IL-6 detections.
出处 《实用临床医药杂志》 CAS 2014年第9期144-145,共2页 Journal of Clinical Medicine in Practice
关键词 慢性阻塞性肺病 降钙素原 白介素-6 hronic obstructive pulmonary disease procalcitonin interleukin-6
  • 相关文献

参考文献6

二级参考文献31

共引文献6575

同被引文献37

  • 1颜雪琴,金玲湘,戴元荣.老年慢性阻塞性肺疾病白介素和肿瘤坏死因子-α测定的临床意义[J].实用老年医学,2007,21(1):33-35. 被引量:8
  • 2Vestbo J,Hurd SS,Agust i AG,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary[J].Am J Respir Crit Care Med,2013,187(4):347-365.
  • 3Vestbo J,Hurd SS,Rodriguez-Roisin R.The 2011 revision of the global strategy for the diagnosis,management and prevention of COPD - why and what?[J].Clin Respir J,2012,6(4):208-214.
  • 4Global Initiative for Chronic Obstructive Lung Disease.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease.(Updated.2014).Chap.2.[R].(2014-01- 18)[2014-01-18].http://www.goldcopd.org.
  • 5Global Initiative for Chronic Obstructive Lung Disease.Global Strategy for The Diagnosis,Management and Prevention of COFD.(Updated.2015).Chap.2.[R].(2015-01- 18)[2015-01-28].http://www.goldcopd.org.
  • 6Bafadhel M,Clark TW,Reid C,et al.Procalcitoniii and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD[J].Chest,2011,139(6):1410-1418.
  • 7Falsey AR,Becker KL,Swinburne AJ,et al.Utility of serum procalcitonin values in patients with acute exacerbations of chronicobstructive pulmonary disease:a cautionary note[J].Int J Chron Obstruct Pulmon Dis,2012(7):127-135.
  • 8Snide RH Jr, Nylen ES, Becker KL. Procalcitonin and itscomponent peptides in systemic inflammation [ J ]. J InvestigMed, 1997,45(9) :552-560.
  • 9Fisher LA,Kikkawa DO,Rivier JE,et al. Stimulation of nora-drenergic sympathetic outflow by ealcitonin gene-related pep-tide[J].Nature,1983,305(5934) :534-536.
  • 10秦娥.慢性阻塞性肺疾病急性加重期患者血清降钙素原测定的临床意义[J].现代实用医学,2010,22(6):676-677. 被引量:19

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部